SARS-CoV-2 antibody status in patients with cancer, health care workers
2021-05-28
(Press-News.org) What The Study Did: This study evaluates whether there are differences in SARS-CoV-2 seroprevalence and antibody levels in patients with cancer compared with health care workers in Japan.
Authors: Tatsuya Yoshida, M.D., Ph.D., of the National Cancer Center Hospital in Tokyo, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2021.2159)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2159?guestAccessKey=8aeadda1-2dff-4136-9127-a1ac36668722&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=053121
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-28
What The Study Did: Socioeconomic disparities in respiratory health over the past six decades in the United States are described in this study.
Authors: Adam W. Gaffney, M.D., of the Cambridge Health Alliance in Cambridge, Massachusetts, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2021.2441)
Editor's Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # ...
2021-05-28
What The Study Did: Study results suggest that reinfections are rare events and that patients who have recovered from COVID-19 have a lower risk of reinfection. However, the observation ended before SARS-CoV-2 variants began to spread, and it is unknown how well natural immunity to the wild-type virus will protect against variants. .
Authors: Nicola Mumoli, M.D., of the Ospedale Fornaroli in Magenta, Italy, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2021.2959)
Editor's ...
2021-05-28
What The Study Did: This survey study examined the associations of having an incarcerated immediate or extended family member with perceived well-being and change in projected life expectancy among adults in the United States.
Authors: Ram Sundaresh, M.D., M.S., of the University of California, Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.11821)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict ...
2021-05-28
What The Study Did: Researchers estimated the extent Medicare Part B medical services would have been subject to prior authorization under private insurance coverage policies and calculated the associated spending.
Authors: Aaron L. Schwartz, M.D., Ph.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2021.0859)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author ...
2021-05-28
What The Study Did: Researchers examined social connectedness among Medicare beneficiaries during the COVID-19 pandemic.
Authors: Wesley John Talcott, M.D., M.B.A., the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2021.2348)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free ...
2021-05-28
As hospitals, insurance companies and policy makers seek to improve healthcare quality and reduce rising medical costs, one important metric used to assess clinicians hinges on how patients feel about their healthcare experience. Many healthcare providers and policy makers fear that increased pressure to please patients -- and ensure high satisfaction ratings as a result -- could lead to overuse of low-value care that doesn't provide any clinical benefit while unnecessarily ratcheting up medical bills.
But new research from the University of Chicago and Harvard Medical School may alleviate some of those concerns. The study, published May 28 in END ...
2021-05-28
New research results for patients with breast and HPV-associated throat cancers are the highlights among 23 presentations by ECOG-ACRIN Cancer Research Group researchers at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, occurring virtually June 4-8. The National Cancer Institute (NCI), part of the National Institutes of Health, funded these studies.
Breast Cancer
Platinum chemotherapy fails in phase III trial for triple-negative breast cancer, basal-like subtype
Abstract 605: About 80% of triple-negative breast cancers (TNBC) are a subtype called 'basal-like.' ...
2021-05-28
Your immune system is always busy fighting incoming threats. It consists of a system of cells, and when there is a shortage of cells, it affects the performance of the immune system.
This is seen in e.g. cancer patients following chemotherapy. This is because chemotherapy targets all the cells in your body, including the stem cells in your bone marrow, which were meant to develop into new immune cells. This means that the immune system then lacks cells to fight new infections.
There are drugs that can harvest stem cells from the bone marrow, so that they can be returned to the patients after treatment. They then develop into new immune cells, enabling the body to once again fight incoming threats. But previously, we lacked ...
2021-05-28
COLUMBUS, Ohio - If you've watched a slasher movie, you've probably been exposed to the final girl trope - a closing scene of a white, suburban teenage girl who triumphed over a threatening monster and lived to tell the tale.
But her story doesn't stop there - in some ways, a whole new life, overshadowed by trauma, has only just begun, Ohio State University graduate student Morgan Podraza posits in an article published in the journal Horror Studies.
Consider actor Jamie Lee Curtis' depiction of Laurie Strode in the Halloween film released in 2018, 40 years after her friends were murdered by Michael Myers on Halloween night. ...
2021-05-28
East Hanover, NJ. May 28, 2021. An international team of multiple sclerosis (MS) experts has identified four under-researched areas that are critical to advancing symptom management for progressive MS, recommending interdisciplinary collaboration among scientists, clinicians, industry leaders, and those with progressive MS. Their call to action was published in Multiple Sclerosis Journal on March 15, 2021, in the article "Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance" (doi: 10.1177/1352458521999970). The Alliance was represented ...
LAST 30 PRESS RELEASES:
[Press-News.org] SARS-CoV-2 antibody status in patients with cancer, health care workers